Why is Thorazine (chlorpromazine) effective in managing agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Thorazine (Chlorpromazine) is Effective for Agitation

Thorazine works for agitation primarily through its sedative and antipsychotic effects at subcortical levels of the central nervous system, though it is no longer recommended as a first-line agent due to limited evidence, significant side effects including hypotension and seizures, and superior alternatives now available. 1, 2

Mechanism of Action

Chlorpromazine exerts its anti-agitation effects through multiple pharmacological actions, though the precise therapeutic mechanism remains incompletely understood 1:

  • Strong sedative activity at subcortical levels of the CNS, which directly reduces behavioral activation and agitation 1
  • Psychotropic effects that address the underlying psychotic symptoms often driving agitated behavior 1
  • Strong antiadrenergic activity that contributes to calming effects but also causes problematic hypotension 1
  • Weaker anticholinergic and antihistaminic properties that add to sedation 1

Critical Evidence Limitations

The evidence base for chlorpromazine in acute agitation is remarkably poor despite decades of use 2:

  • Only one small study (n=30) meets modern inclusion criteria comparing chlorpromazine to haloperidol for psychosis-induced aggression 2
  • No difference in efficacy was demonstrated compared to haloperidol, requiring similar numbers of repeat injections 2
  • Quality of evidence is limited, poor, and dated according to systematic review 2

Significant Safety Concerns

Chlorpromazine carries substantial risks that make it inferior to modern alternatives 2:

  • Sudden, serious hypotension occurred in 2 patients in the limited available trial (versus zero with haloperidol) 2
  • Status epilepticus developed in one patient receiving chlorpromazine 2
  • Anticholinergic side effects can potentially worsen agitation in patients with anticholinergic delirium or sympathomimetic intoxication 3

Current Guideline Recommendations

Modern guidelines explicitly recommend against routine chlorpromazine use 4:

  • The World Health Organization states chlorpromazine should only be offered as first-line treatment when atypical antipsychotics cannot be assured or are cost-prohibitive 4
  • Where drugs that have been better evaluated are available, it may be best to avoid use of chlorpromazine 2
  • Atypical antipsychotics (risperidone, olanzapine, quetiapine, ziprasidone) are preferred alternatives when availability and cost permit, offering comparable efficacy with significantly fewer extrapyramidal side effects 4

Preferred Modern Alternatives

Current evidence supports superior options for acute agitation 3, 4:

  • Haloperidol has by far the best evidence base among conventional antipsychotics for treatment of agitation 3
  • Benzodiazepines (lorazepam 2-4 mg) are at least as effective as conventional antipsychotics with multiple Class II studies supporting their use 3
  • Ziprasidone IM 20 mg rapidly reduces acute agitation with notably absent movement disorders including extrapyramidal symptoms and dystonia 3, 4
  • Combination therapy with an antipsychotic plus benzodiazepine may be superior to either agent alone 5

Clinical Bottom Line

Where chlorpromazine is used for acute aggression or where choices are limited, relevant trials are urgently needed 2. The historical use of chlorpromazine for agitation reflects an era before better-studied alternatives became available. Clinicians should prioritize atypical antipsychotics or benzodiazepines over chlorpromazine given the superior evidence base, better tolerability, and lower risk profile of modern agents 4, 2, 5.

References

Research

Chlorpromazine for psychosis induced aggression or agitation.

The Cochrane database of systematic reviews, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternatives to Haloperidol for Managing Agitation and Psychosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacological management of agitation in emergency settings.

Emergency medicine journal : EMJ, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.